Early Survival Benefit Validates Addition of Radium-244 to Metastatic Prostate Cancer

In men with metastatic castration-resistant prostate cancer (mCRPC), the addition of Radium-233 (Ra233) (Xofigo, ...

OCTOBER 30, 2024